Keyphrases
Endomyocardial Biopsy
66%
Response Predictors
66%
Heart Failure
66%
Molecular Pathology
66%
Pharmacotherapy
33%
Predictive Algorithm
33%
Pump Failure
25%
Sudden Cardiac Death
16%
Predictive Tool
16%
MicroRNA
16%
Health Costs
16%
Biopsy Specimen
16%
Proteomic Analysis
16%
Staggering
16%
Patient's Will
16%
Non-responders
16%
Genomic Analysis
16%
Diagnosis Management
16%
Molecular Understanding
16%
Health Care Costs
16%
Multicenter Trial
16%
Array Data
16%
Early Identification
16%
Heart Failure Patients
16%
Multicenter Clinical Trial
16%
Predictive Models
16%
Patient Identification
16%
Beta-blocker Therapy
16%
Dilated Cardiomyopathy
16%
Patient Cohort
16%
Ejection Fraction
16%
Target Molecule
16%
Proteomic Assay
16%
Device Therapy
16%
Functional Capacity
16%
Molecular Profiling
16%
Molecular Biomarkers
16%
Clinical Decisions
16%
Clinical Tool
16%
Diagnostic Classification
16%
Heart Failure Progression
16%
Protein Changes
16%
Patient Care
16%
Mechanical Support
16%
Prevalent Diseases
16%
Predictive Value
16%
Congestive Heart Failure
16%
Quantitative Proteomics
16%
Disease Progression
16%
Western Societies
16%
Medicine and Dentistry
Heart Failure
100%
Molecular Pathology
100%
Heart Muscle Biopsy
80%
Disease
40%
Health Care Cost
40%
Drug Therapy
40%
Identified Patient
20%
Targeting Protein
20%
Ejection Fraction
20%
Proteomics
20%
Sudden Cardiac Death
20%
Patient Care
20%
microRNA
20%
Congestive Heart Failure
20%
6 Diazo 5 Oxonorleucine
20%
Quantitative Proteomics
20%
Clinical Trial
20%
Biological Marker
20%
Disease Exacerbation
20%
Functional Status
20%
Dilated Cardiomyopathy
20%
Device Therapy
20%
Transplantation
20%
Molecular Profiling
20%